Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Capital Expenditures (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Capital Expenditures for 3 consecutive years, with $43053.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Capital Expenditures fell 89.47% year-over-year to $43053.0, compared with a TTM value of $1.2 million through Sep 2025, down 85.47%, and an annual FY2024 reading of $2.6 million, down 69.98% over the prior year.
  • Capital Expenditures was $43053.0 for Q3 2025 at SBC Medical Group Holdings, down from $306706.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $6.2 million in Q4 2023 and bottomed at $43053.0 in Q3 2025.
  • Average Capital Expenditures over 3 years is $1.2 million, with a median of $499655.0 recorded in 2024.
  • The sharpest move saw Capital Expenditures crashed 90.55% in 2024, then crashed 63.87% in 2025.
  • Year by year, Capital Expenditures stood at $6.2 million in 2023, then plummeted by 90.55% to $590358.0 in 2024, then tumbled by 92.71% to $43053.0 in 2025.
  • Business Quant data shows Capital Expenditures for SBC at $43053.0 in Q3 2025, $306706.0 in Q2 2025, and $253725.0 in Q1 2025.